Synthesis and Preclinical Validation of Novel P2Y1 Receptor Ligands as a Potent Anti-Prostate Cancer Agent

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-55194-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Preclinical Evaluation of Liposomal C8 Ceramide as a Potent Anti-Hepatocellular Carcinoma Agent

PLoS ONE
Multidisciplinary
2016English

Largazole as a Novel and Selective Anti-Breast Cancer Agent

2011English

Biological Activities of Fusarochromanone: A Potent Anti-Cancer Agent

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Full Preclinical Validation of the 123i-Labeled Anti-Psma Antibody Fragment ScFvD2B for Prostate Cancer Imaging

Oncotarget
Oncology
2016English

Design, Synthesis and In-Silico Studies of Novel Chalcones as Anti-Prostate Cancer and Cathepsin B Inhibitors

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2017English

Antitumor Agents. 254. Synthesis and Biological Evaluation of Novel Neo-Tanshinlactone Analogues as Potent Anti-Breast Cancer Agents

English

Synthesis and Characterization of Substituted Bisbenzoxazine as Potent Antimicrobial Agent

International Letters of Chemistry, Physics and Astronomy
2015English

Development of a Novel Anti-Hif-1α Screening System Coupled With Biochemical and Biological Validation for Rapidly Selecting Potent Anti-Cancer Compounds

Journal of Cancer
Oncology
2014English

Development, Optimization, and Validation of Novel Anti-Tem1/Cd248 Affinity Agent for Optical Imaging in Cancer

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy